GSB 7.1 Standardlösung

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy

OK

Further update of the Diabetes Surveillance

Many other indicators of the Diabetes Surveillance were updated in July 2024. Particular attention was paid to diabetes and its healthcare in childhood and adolescence as well as the contextual factors. This is the last planned update of the Diabetes Surveillance. Key indicators will be transferred to an overarching health information system at the end of this project phase as part of the extension to an NCD system, which is currently being set up and will go live at the end of the year.

Diabetes and its treatment in children and adolescents

Type 1 diabetes is one of the most common chronic metabolic diseases in childhood and adolescence, in which the immune system destroys insulin-producing cells in the pancreas due to a misdirected reaction, resulting in an absolute insulin deficiency. Treatment with insulin is therefore absolutely essential. Around half of children and adolescents with type 1 diabetes are treated with an insulin pump and around two thirds use continuous glucose monitoring to control their blood sugar levels. Type 2 diabetes, on the other hand, is characterized by a relative insulin deficiency, which often first occurs in adulthood due to unfavorable lifestyle factors. However, children and adolescents can also be affected. The existing time trends for 2022 were continued for the following indicators:

Contextual factors

Contextual-factors play an important role in the prevention of type 2 diabetes. This refers to people's living, working and environmental conditions, but also to health policy measures that can influence the risk of type 2 diabetes in children, adolescents and adults. The time trends for most contextual factors have been updated for 2022:

In addition, the existing time trends for 2022 were continued for other indicators of the Diabetes Surveillance: